Robert A. Verhagen

Direttore/Membro del Consiglio presso ImmunoBiochem Corp.

55 anni

Health Technology

Consumer Services

Profilo

Robert A.
Verhagen is currently a Director at ImmunoBiochem Corp.
Previously, he was the President, Chief Executive Officer & Director at Helix BioPharma Corp.
from 2012 to 2015.
He also held the position of Vice President-Business Development at Spectral Medical, Inc. Verhagen obtained his undergraduate degree and MBA from the University of Alberta.

Posizioni attive di Robert A. Verhagen

Società	Posizione	Inizio
ImmunoBiochem Corp. ImmunoBiochem Corp. BiotechnologyHealth Technology ImmunoBiochem Corp. is a biopharmaceutical company founded in 2007, based in Canada. The private company is focused on developing biological therapeutics to address unmet needs in oncology and immuno-oncology. ImmunoBiochem has worked closely with the University of Toronto, one of the world's leading institutions in research and innovation, on some of its novel programs. The Canadian company uses high-throughput functional screens, bioinformatics, and AI/ML to discover novel tumor targets in the tumor microenvironment, particularly in the cancer cell secretome. The company is a Johnson & Johnson Innovation JLABS alumnus and is headquartered in the heart of Canada's largest biomedical research hub.	Direttore/Membro del Consiglio	-

Tutte le posizioni attive di Robert A. Verhagen

Precedenti posizioni note di Robert A. Verhagen

Società	Posizione	Fine
HELIX BIOPHARMA CORP.	Amministratore Delegato	01/11/2015
SPECTRAL MEDICAL INC.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Robert A. Verhagen

Formazione di Robert A. Verhagen

University of Alberta

Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Robert A. Verhagen

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
SPECTRAL MEDICAL INC.	Health Technology
HELIX BIOPHARMA CORP.	Health Technology

Aziende private	1
ImmunoBiochem Corp. ImmunoBiochem Corp. BiotechnologyHealth Technology ImmunoBiochem Corp. is a biopharmaceutical company founded in 2007, based in Canada. The private company is focused on developing biological therapeutics to address unmet needs in oncology and immuno-oncology. ImmunoBiochem has worked closely with the University of Toronto, one of the world's leading institutions in research and innovation, on some of its novel programs. The Canadian company uses high-throughput functional screens, bioinformatics, and AI/ML to discover novel tumor targets in the tumor microenvironment, particularly in the cancer cell secretome. The company is a Johnson & Johnson Innovation JLABS alumnus and is headquartered in the heart of Canada's largest biomedical research hub.	Health Technology